We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYPR icon
14301
CALL
Sypris Solutions
SYPR
$47.4M
$2.02K ﹤0.01%
+1,000
New +$2.08K
HIPO icon
14302
PUT
Hippo Holdings
HIPO
$872M
$2.01K ﹤0.01%
148
-14,652
-99% -$220K
RPT
14303
PUT
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$2.01K ﹤0.01%
+200
New +$1.98K
ITP icon
14304
CALL
IT Tech Packaging
ITP
$2.91M
$2.01K ﹤0.01%
4,360
-11,920
-73% -$7.98K
CURV icon
14305
Torrid Holdings
CURV
$219M
$1.98K ﹤0.01%
+669
New +$2.73K
STSA
14306
PUT
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.98K ﹤0.01%
2,200
-9,000
-80% -$26.1K
AVAH icon
14307
PUT
Aveanna Healthcare
AVAH
$2.68B
$1.95K ﹤0.01%
+2,500
New +$2.62K
KBWY icon
14308
PUT
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$309M
$1.95K ﹤0.01%
+100
New +$2K
NMTR
14309
DELISTED
9 Meters Biopharma
NMTR
$1.94K ﹤0.01%
1,539
+149
+11% +$340
AKYA
14310
PUT
DELISTED
Akoya BioSciences
AKYA
$1.91K ﹤0.01%
+200
New +$2.46K
FNA
14311
CALL
DELISTED
Paragon 28, Inc.
FNA
$1.91K ﹤0.01%
+100
New +$1.89K
VCNX
14312
CALL
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$1.91K ﹤0.01%
+14
New +$1.74K
FDUS icon
14313
PUT
Fidus Investment
FDUS
$744M
$1.9K ﹤0.01%
+100
New +$1.9K
AEYE icon
14314
PUT
AudioEye
AEYE
$99.8M
$1.9K ﹤0.01%
+500
New +$2.48K
FBRX icon
14315
PUT
Forte Biosciences
FBRX
$1.57B
$1.9K ﹤0.01%
+76
New +$1.95K
CENN icon
14316
PUT
Cenntro
CENN
$8.63M
$1.89K ﹤0.01%
+7
New +$3.18K
PNACW
14317
DELISTED
Prime Number Acquisition I Corp. Warrant
PNACW
$1.89K ﹤0.01%
+29,100
New +$1.16K
LYRA
14318
PUT
DELISTED
LYRA THERAPEUTICS INC
LYRA
$1.88K ﹤0.01%
+12
New +$2.38K
TARA icon
14319
PUT
Protara Therapeutics
TARA
$235M
$1.88K ﹤0.01%
+700
New +$2.21K
RPAR icon
14320
CALL
RPAR Risk Parity ETF
RPAR
$582M
$1.86K ﹤0.01%
+100
New +$1.84K
RPAR icon
14321
PUT
RPAR Risk Parity ETF
RPAR
$582M
$1.86K ﹤0.01%
+100
New +$1.84K
ETHZW
14322
DELISTED
ETHZilla Corp Warrant
ETHZW
$1.84K ﹤0.01%
+29,186
New +$1.52K
NWG icon
14323
CALL
NatWest
NWG
$76B
$1.83K ﹤0.01%
+284
New +$1.66K
WLDSW icon
14324
Wearable Devices Ltd Warrant
WLDSW
$1.82K ﹤0.01%
+21
New +$2.43K
CBIO
14325
PUT
Crescent Biopharma
CBIO
$637M
$1.82K ﹤0.01%
+6
New +$884

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.